PRTN3 and rheumatoid arthritis: As illustrated in Table 2, there were no significant differences in demographic data, traditional CVD risk factors, BMI, or proportion of seropositivity for rheumatoid factor (RF) or anticitrullinated peptide antibody (ACPA) among RA patients with different apoE genotypes.